Paragon Care Ltd (ASX: PGC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Paragon Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $207.04 million
P/E Ratio 19.07
Dividend Yield 4.07%
Shares Outstanding 667.87 million
Earnings per share 0.015
Dividend per share 0.01
Year To Date Return 31.11%
Earnings Yield 5.24%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Paragon Care Ltd (ASX: PGC)
    Latest News

    a woman
    Growth Shares

    How I'd invest $25,000 into ASX shares today

    This is how I’d invest $25,000 into ASX shares today.

    Read more »

    a woman
    52-Week Lows

    3 ASX shares at 52-week lows: Time to buy?

    The Costa Group Holdings Ltd (ASX:CGC) share price is one of three that feel to a 52-week low on Thursday.…

    Read more »

    a woman
    Cheap Shares

    Are Telstra shares and these 2 ASX stocks too cheap to ignore?

    Are Telstra Corporation Ltd (ASX:TLS) shares and these 2 ASX stocks too cheap to ignore?

    Read more »

    a woman
    Personal Finance

    How to retire at 40 with ASX shares

    If you set your mind and money to it, I think it’s possible to retire at 40.

    Read more »

    a woman
    ⏸️ Dividend Shares

    Why you should own this dividend share instead of Commonwealth Bank

    I think you should own Paragon Care Ltd (ASX:PGC) shares instead of Commonwealth Bank of Australia (ASX:CBA).

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes higher Thursday: 10 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Thursday.

    Read more »

    a woman
    Speculative

    7 small cap shares to watch in 2019

    BWX Ltd (ASX:BWX) shares are one of seven at the small end of the market to watch in 2019...

    Read more »

    a woman
    Growth Shares

    3 ASX shares to buy before the end of 2018

    These 3 ASX shares could be worth buying before the end of 2018.

    Read more »

    a woman
    Cheap Shares

    2 cheap ASX shares to buy to beat the ASX 200

    These 2 ASX shares are cheap and could beat the ASX 200.

    Read more »

    a woman
    ⏸️ Income

    2 growing small cap dividend shares to buy

    Could these small cap dividend shares be better options that Westpac Banking Corp (ASX:WBC)?

    Read more »

    a woman
    ⏸️ Investor Education

    Is it time to be greedy and buy ASX shares?

    Could it be time to be greedy and buy ASX shares?

    Read more »

    a woman
    Growth Shares

    3 small cap healthcare shares to buy today

    Volpara Health Technologies Ltd (ASX:VHT) shares are one of three at the small end of the healthcare sector to buy this…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    18 Sep 2023 $0.0060 100.00% Final 06 Oct 2023
    14 Mar 2023 $0.0060 100.00% Interim 05 Apr 2023
    12 Sep 2022 $0.0060 100.00% Final 04 Oct 2022
    21 Mar 2022 $0.0060 100.00% Interim 26 Apr 2022
    13 Sep 2021 $0.0100 100.00% Final 01 Oct 2021
    21 Mar 2019 $0.0110 100.00% Interim 26 Apr 2019
    14 Sep 2018 $0.0200 100.00% Final 12 Oct 2018
    15 Mar 2018 $0.0110 100.00% Interim 12 Apr 2018
    07 Sep 2017 $0.0000 100.00% Final 06 Oct 2017
    09 Mar 2017 $0.0110 100.00% Interim 06 Apr 2017
    15 Sep 2016 $0.0140 100.00% Final 06 Oct 2016
    09 Mar 2016 $0.0080 100.00% Interim 06 Apr 2016
    08 Oct 2014 $0.0075 100.00% Final 31 Oct 2014
    07 Mar 2014 $0.0050 100.00% Interim 31 Mar 2014
    04 Oct 2013 $0.0100 100.00% Final 31 Oct 2013

    PGC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Paragon Care Ltd

    Paragon Care Ltd is a medical device company. It is a provider of medical equipment, devices, and consumables to the healthcare market. The company provides solutions to various healthcare markets Aged care; Hospital and Acute care; Primary Care; Eye Care; Storage Solutions; and E-Health. The group is organized into four operating segments: Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology and the majority of its revenues are generated from services and technology.

    PGC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $0.31 $0.02 6.78% 3,823,365 $0.30 $0.31 $0.29
    27 Mar 2024 $0.30 $0.02 7.14% 913,939 $0.28 $0.30 $0.28
    26 Mar 2024 $0.28 $0.00 0.00% 698,554 $0.28 $0.29 $0.28
    25 Mar 2024 $0.29 $0.00 0.00% 582,414 $0.29 $0.29 $0.28
    22 Mar 2024 $0.29 $0.02 7.41% 894,775 $0.27 $0.29 $0.27
    21 Mar 2024 $0.27 $0.00 0.00% 11,415,855 $0.27 $0.27 $0.27
    20 Mar 2024 $0.27 $0.01 3.85% 1,111,517 $0.26 $0.27 $0.26
    19 Mar 2024 $0.26 $0.00 0.00% 2,835,521 $0.26 $0.27 $0.26
    18 Mar 2024 $0.26 $0.00 0.00% 1,736,848 $0.26 $0.26 $0.26
    15 Mar 2024 $0.26 $0.00 0.00% 2,131,060 $0.26 $0.26 $0.26
    14 Mar 2024 $0.26 $0.01 3.92% 1,268,487 $0.26 $0.26 $0.26
    13 Mar 2024 $0.26 $0.00 0.00% 990,256 $0.26 $0.26 $0.26
    12 Mar 2024 $0.26 $-0.01 -3.85% 1,840,305 $0.27 $0.27 $0.25
    11 Mar 2024 $0.26 $-0.01 -3.70% 3,917,171 $0.27 $0.27 $0.26
    08 Mar 2024 $0.27 $0.00 0.00% 7,606,820 $0.27 $0.28 $0.26
    07 Mar 2024 $0.27 $0.00 0.00% 4,722,764 $0.27 $0.28 $0.27
    06 Mar 2024 $0.27 $-0.02 -6.90% 2,800,144 $0.29 $0.29 $0.26
    05 Mar 2024 $0.29 $0.09 43.90% 7,799,998 $0.25 $0.31 $0.25
    29 Feb 2024 $0.21 $-0.01 -4.76% 924,055 $0.22 $0.22 $0.20
    28 Feb 2024 $0.21 $0.00 0.00% 247,430 $0.22 $0.22 $0.21
    27 Feb 2024 $0.21 $-0.01 -4.65% 359,554 $0.22 $0.22 $0.21

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Nov 2023 John Walstab Issued 1,572,380 $275,166
    Issue of securities. 2,594,409 Unquoted Performance Rights
    06 Oct 2023 Geoffrey Sam Buy 89,460 $13,629
    Dividend Reinvestment Plan (DRP).
    06 Oct 2023 Brent Stewart Buy 140,987 $21,479
    Dividend Reinvestment Plan (DRP).
    06 Oct 2023 Shane Tanner Buy 49,228 $7,499
    Dividend Reinvestment Plan (DRP).
    06 Oct 2023 John Walstab Buy 100 $15
    Dividend Reinvestment Plan (DRP).
    06 Oct 2023 John Walstab Buy 4,917,418 $749,173
    Dividend Reinvestment Plan (DRP).
    28 Jun 2023 Mark Hooper Buy 914,347 $201,156
    On-market trade.
    05 Apr 2023 Mark Hooper Issued 1,500,000 $382,500
    Issue of securities. Employment Agreement

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Shane Francis Tanner Non-Executive DirectorNon-Executive Chairman Dec 2005
    Mr Tanner has experience and background in the Australian healthcare industry. Shane has been integral to several small acquisitions in the business over a long period. He has also helped to establish and guide several Healthcare and Life Science businesses and he was the founding CEO of Symbion Health, one of Australia's diagnostic businesses and was the founding Chairman and led the IPO of Vitura Australia, Vision Eye Institute and Rhythm Biosciences. He is also Member of Investment and Risk Committee.
    Mr Philip (Phil) Nicholl Executive Director Nov 2019
    Mr Nicholl is currently the CEO of one of Paragon's businesses, a company in the orthopaedics market in Australia and New Zealand. Mr Nicholl has experience in the medical devices industry having occupied senior executive roles for the companies including Stryker and Cochlear.
    Mr John Walstab Chief Executive OfficerManaging Director Feb 2022
    Mr Walstab has over 40 years of experience in medical equipment distribution with a focus on healthcare technologies in Asia. Prior roles include Managing Director of Advanced Technology, Laboratories (Phils Medical Systems ANZ) and Business Manager for Medtel Australia. John is a member of the Australian Institute of Company Directors and sits on various Boards including Central Sydney Private Hospital, CBTR Healthcare Solutions and SMS Healthcare.
    Mr Geoffrey Joseph Sam Non-Executive Director Jun 2016
    Mr Sam has held numerous ASX listed board positions including Chairman of Money 3, Director of Hutchinson's Childcare Services and Managing Director of Nova Health. Prior to his appointments to ASX listed companies, Geoffrey undertook numerous Chief Executive positions at Adelaide based hospitals. He is the Co-Founder and Director of Healthecare Group Pty Ltd, it comprises of 17 hospitals and Day surgeries. He is also a member of the Risk Committee.
    Mr Alan Timothy McCarthy Non-Executive Director Feb 2022
    Mr McCarthy experience spans public health and private health services across Asia Pacific for more than 32 years, including CEO at Alpenglow, Australia and SRG NZ, MD of Philips ANZ, Vice-President Asia Pacific at CareFusion, Country Manager ANZ at Cardinal Health, and GM of Diagnostic Imaging at Mayne Health/Health Care of Australia. Currently he is a Non-Executive Director of Qscan Services Pty Ltd and RHC Group Ltd (Pacific Radiology, Auckland Radiology) and Bay Radiology and is also CEO of AdvaHealth Solutions Sg. He is Chairman of Investment Committee.
    Mr Brent Stewart Non-Executive Director May 2018
    Mr Stewart is a company executive and director having occupied numerous senior executive and board roles over the past 25 years. He established and grew a company in Australia and New Zealand (Market Equity Pty Ltd) before selling to a multinational group (Aegis PLC). Brent has association with various segments of the healthcare sector in Australia and internationally. Currently, Brent occupies Non-Executive roles at HBF Health Ltd, Etherington Inc and Argonaut Ltd. He is Chair of Risk Committee and member of Investment Committee.
    Ms Claire Newstead-Sinclair Joint Company Secretary Aug 2022
    -
    Ms Melanie Jaye Leydin Company Secretary Jun 2018
    -
    Josephine De Martino Chief Financial Officer
    -
    Melanie Jaye Leydin Company Secretary
    -
    Phil Nicholl Executive General Manager ParagonCare ANZ
    -
    Claire Newstead-Sinclair Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr John Walstab 124,460,317 18.88%
    Pioneer Pharma Australia Pty Ltd 53,297,068 8.08%
    Citicorp Nominees Pty Limited 34,688,468 5.26%
    First Samuel Ltd Acn 086243567 (Anf Its Mda Clients A/C) 28,703,046 4.35%
    HSBC Custody Nominees (Australia) Limited 27,859,397 4.23%
    J P Morgan Nominees Australia Pty Limited 22,319,120 3.39%
    National Nominees Limited 16,669,778 2.53%
    Berne No 132 Nominees Pty Ltd (737539 A/C) 16,567,378 2.51%
    National Nominees Limited i 16,069,332 2.44%
    Mr Young Chun Kim 10,692,000 1.62%
    Mr Phillip Sidney 10,627,809 1.61%
    Realm Group Pty Limited 7,520,575 1.14%
    Bnp Paribas Noms Pty Ltd (Drp) 5,316,943 0.81%
    Jmt Investment Group Vic Pty Ltd (John Turner Super Fund A/C) 5,000,000 0.76%
    Negroni Holdings Pty Ltd (The Dfn A/C) 4,727,531 0.72%
    Mrs Sandra Joan Mcdonald & Mr Andrew Mcdonald (Mcdonald Family S/Fund A/C) 4,502,524 0.68%
    Dixson Trust Pty Limited 4,143,800 0.63%
    Jmt Investment Group Vic Pty Ltd 4,000,000 0.61%
    Mr Richard Albarran 3,942,129 0.60%
    Mr Drew Townsend 3,942,128 0.60%

    Profile

    since

    Note